跳到主要內容

邱懷萱助理研究員

▍聯繫資訊
  • 辦公室：第十共研
  • 電話：02-33662569
  • Email：huaihsuanchiu@ntuh.gov.tw
  • 實驗室網站：（建置中）

 

▍學歷
  • 國立台灣大學藥學所  博士
  • 國立中央大學化學系  學士

 

 huaihsuanchiu
▍經歷

  • 國立台灣大學藥學所 博士後研究員

  • University of Illinois Urbana-Champaign visiting scholar

 
▍主要專長
  • 藥物分析
  • 代謝體學分析
  • 生醫質譜分析

 

▍研究方向

代謝體學分析、藥物分析

 

▍近五年論文發表
  1. Chi TH, Lo C, Lin SY, Liang YH, Chang WC, Yeh CY, Chiu HH*, Kuo CH*. A novel approach for quantifying therapeutic monoclonal antibodies in blood through liquid chromatography-tandem mass spectrometry. Anal Chim Acta. 2025;1371: 344427. doi:10.1016/j.aca.2025.344427 (co-corresponding author)
  2. Tai YH, Kao CY, Zhang YP, Chiou YJ, Chiu HH, Thuy TTD, Liao HW. An integrated platform for investigating drug-microbial interactions to support pharmacomicrobiomics studies. Talanta. 2025;283:127094. doi:10.1016/j.talanta.2024.127094
  3. Cheng CN, Tsai YJ, Chiu HH, Chen TW, Lin CH, Lu YS, Kuo CH. Evaluation of the association between bevacizumab concentration and clinical outcomes in patients with breast cancer brain metastasis. Heliyon. 2025;11(1):e41390. doi:10.1016/j.heliyon.2024.e41390
  4. Wang YW, Hou HA, Lin CC, Lin HY, Chen PZ, Kuo CH, Chiu HH, Chuang CC, Chen YJ, Lin SW. Early Therapeutic Drug Monitoring Optimizes Teicoplanin Use in Febrile Neutropenic Patients with Hematological Malignancies. Advances in therapy. 2024;41(7):2966-77. doi:10.1007/s12325-024-02884-z
  5. Liu CI, Liu CM, Chiu HH, Chuang CC, Hwang TJ, Hsieh MH, Chien YL, Lin YT, Yen K, Liu CC. Verification of successful maintenance by serum drug level during a guided antipsychotic reduction to reach minimum effective dose (GARMED) trial. Psychological medicine. 2024;54(14):1-11. doi:10.1017/s0033291724002356
  6. Chiu HH, Lin SY, Zhang CG, Tsai CC, Tang SC, Kuo CH. A comparative study of plasma and dried blood spot metabolomics and its application to diabetes mellitus. Clin Chim Acta. 2024;552:117655. doi:10.1016/j.cca.2023.117655
  7. Kao CY, Chang CT, Kuo PY, Lin CJ, Chiu HH, Liao HW. Sequential isolation of metabolites and lipids from a single sample to achieve multiomics by using TRIzol reagent. Talanta. 2023;258:124416. doi:10.1016/j.talanta.2023.124416
  8. Chiu HH, Tsai YJ, Lo C, Lin CH, Tsai IL, Kuo CH. Development of an efficient mAb quantification assay by LC-MS/MS using rapid on-bead digestion. Anal Chim Acta. 2022;1193:339319. doi:10.1016/j.aca.2021.339319 (co-first author)
  9. Chiu HH, Tsai YJ, Lo C, Liao HW, Lin CH, Tang SC, Kuo CH. Development of an LC-MS/MS method to simultaneously quantify therapeutic mAbs and estimate hematocrit values in dried blood spot samples. Anal Chim Acta. 2022;1189:339231. doi:10.1016/j.aca.2021.339231
  10. Lu WH, Chiu HH, Kuo HC, Chen GY, Chepyala D, Kuo CH. Using matrix-induced ion suppression combined with LC-MS/MS for quantification of trimethylamine-N-oxide, choline, carnitine and acetylcarnitine in dried blood spot samples. Anal Chim Acta. 2021;1149:338214. doi:10.1016/j.aca.2021.338214
  11. Hsieh CC, Chiu HH, Wang CH, Kuo CH. Aspirin Modifies Inflammatory Mediators and Metabolomic Profiles and Contributes to the Suppression of Obesity-Associated Breast Cancer Cell Growth. International journal of molecular sciences. 2020;21(13). doi:10.3390/ijms21134652
  12. Chiu HH, Kuo CH. Gas chromatography-mass spectrometry-based analytical strategies for fatty acid analysis in biological samples. Journal of food and drug analysis. 2020;28(1):60-73. doi:10.1016/j.jfda.2019.10.003 (review article)